Treatment of epilepsy in adults: expert opinion, 2005. (Q46652012)

24 December 2017

title

Treatment of epilepsy in adults: expert opinion, 2005. (English)

1 reference

24 December 2017

author name string

Steven Karceski

series ordinal

1 reference

24 December 2017

Martha J Morrell

series ordinal

1 reference

24 December 2017

Daniel Carpenter

series ordinal

1 reference

24 December 2017

publication date

1 September 2005

1 reference

24 December 2017

published in

Epilepsy Behavior

1 reference

24 December 2017

volume

7 Suppl 1

1 reference

24 December 2017

page(s)

S1-64; quiz S65-7

1 reference

24 December 2017

Lamotrigine. A review of its pharmacological properties and clinical efficacy in epilepsy

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.06.001

Gabapentin (Neurontin) as add-on therapy in patients with partial seizures: a double-blind, placebo-controlled study. The International Gabapentin Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.06.001

Gabapentin as add-on therapy in refractory partial epilepsy: a double-blind, placebo-controlled, parallel-group study. The US Gabapentin Study Group No. 5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.06.001

Tiagabine therapy for complex partial seizures. A dose-frequency study. The Tiagabine Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.06.001

Levetiracetam for partial seizures: results of a double-blind, randomized clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.06.001

Comparative anticonvulsant and mechanistic profile of the established and newer antiepileptic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.06.001

New formulations of drugs in epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.06.001

Use of clobazam for the treatment of refractory complex partial seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.06.001

Management strategies for refractory localization-related seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.06.001

Efficacy of clobazam as add-on therapy in patients with refractory partial epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.06.001

Managing epilepsy in tuberous sclerosis complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.06.001

A randomized, controlled trial of surgery for temporal-lobe epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.06.001

7 January 2021

Early epilepsy surgery.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.06.001

Safety and efficacy of two pregabalin regimens for add-on treatment of partial epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.06.001

Pregabalin add-on treatment: a randomized, double-blind, placebo-controlled, dose-response study in adults with partial seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.06.001

Dose-response trial of pregabalin adjunctive therapy in patients with partial seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.06.001

Evidence-based medicine and antiepileptic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.06.001

Individual patient data meta-analysis of randomized anti-epileptic drug monotherapy trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.06.001

A method for the detailed assessment of the appropriateness of medical technologies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.06.001

Prognostic factors in absence seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.06.001

Diagnosis and treatment of epilepsy in children and adolescents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.06.001

Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the [...]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.06.001

Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the [...]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.06.001

Lamotrigine and Seizure Aggravation in Severe Myoclonic Epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.06.001

Exacerbation of juvenile myoclonic epilepsy with lamotrigine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.06.001

Lamotrigine for patients with juvenile myoclonic epilepsy following prior treatment with valproate: results of an open-label study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.06.001

Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.06.001

A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. The Department of Veterans Affairs Epilepsy Cooperative Study No. 264 Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.06.001

Selection of antiepileptic drug polytherapy based on mechanisms of action: the evidence reviewed

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.06.001

On the association between valproate and polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.06.001

Obesity and endocrine disorders in women taking valproate for epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.06.001

Valproate, lamotrigine, and insulin-mediated risks in women with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.06.001

Effects of epilepsy on women's reproductive health.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.06.001

Predictors of ovulatory failure in women with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.06.001

Acute and chronic seizures in patients older than 60 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.06.001

Choice and use of newer anticonvulsant drugs in older patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.06.001

Current discoveries on the cognitive effects of antiepileptic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.06.001

Special populations: the management of seizures in HIV-positive patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.06.001

A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.06.001

A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.06.001

Neuropsychological effects of epilepsy and antiepileptic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.06.001

Evidence-based pharmacologic treatment for people with severe mental illness: a focus on guidelines and algorithms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.06.001

Mortality in epilepsy: driving fatalities vs other causes of death in patients with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.06.001

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.06.001

Driving restrictions and people with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.06.001

10.1016/J.YEBEH.2005.06.001

7 January 2021

Identifiers

DOI

1 reference

24 December 2017

1 reference

24 December 2017